Chimerix
Home
about Chimerix
About Chimerix
Strategy
Licensing Opportunities
Commitment
Management Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Investors
Therapeutic Programs
Pipeline
CMX001
dsDNA viruses
Smallpox
CMX001 Publications & Presentations
CMX157
HIV
CMX157 Publications & Presentations
Research Programs
Clinical Trials
Scientific Foundation
Scientific Foundation
Lipid Antiviral Conjugate Technology
Chimerix Chemical Library
Patents
Investor Relations
Careers
Working at Chimerix
Opportunities
Contact Us
Product Feature
Technology Platform
Featured News & Events
May
16
Chimerix's CMX001 Resistance Data Presented at the 26th International Conference on Antiviral Research
May
13
Chimerix Announces First Quarter 2013 Financial Results
May
10
Data on Chimerix's CMX001 Selected for Two Oral Presentations at the 26th International Conference on Antiviral Research
May
06
Chimerix to Announce First Quarter Financial Results on May 13, 2013
Apr
29
Chimerix Presents at Annual EBMT Meeting: Antiviral Activity of CMX001 in Patients With Life-Threatening Viral Infections
